Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of IPD-1151T (suplatast tosilate) in Interstitial Cystitis
jRCT2080220253Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing IPD-1151T with Placebo (2 arms).
02
Drugs
suplatast tosilate
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2080220253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220253.